McElhaugh Michael J.

Insider profile

McElhaugh Michael J.'s trades of Arbutus Biopharma Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-04-21 2025-04-21 PrS Proposed sale
56,377
486.45
US$1,913,151
56,377 486.45 US$1,913,151
2025-04-15 2025-04-15 PrS Proposed sale
33,055
483.38
US$2,538,860
33,055 483.38 US$2,538,860
2025-02-05 2025-02-04 PlS Planned sale
51,630 -48.6%
287.96
US$1,471,796
51,630 -48.6% 287.96 US$1,471,796
2025-02-04 2025-02-04 PrS Proposed sale
23,790
3.28
US$78,103
23,790 3.28 US$78,103
2024-02-05 2024-02-02 PlS Planned sale
10,164 -0.7%
2.31
US$23,504
10,164 -0.7% 2.31 US$23,504
2021-02-10 2021-02-09 PlS Planned sale
20,000 -1.5%
5.00
US$100,000
20,000 -1.5% 5.00 US$100,000
2020-12-16 2020-12-14 PlS Planned sale
10,000 -0.7%
5.00
US$50,032
10,000 -0.7% 5.00 US$50,032
2020-12-16 2020-12-14 PlS Planned sale
30,000 -2.2%
5.00
US$150,000
30,000 -2.2% 5.00 US$150,000
2020-07-27 2020-07-23 PlS Planned sale
20,000 -1.4%
5.01
US$100,200
20,000 -1.4% 5.01 US$100,200